PTO Form 1581 (Rev 9/2005) |
OMB No. 0651-0054 (Exp. 09/30/2011) |
SOU Extension Request
(15 U.S.C. Section 1051(d))
The table below presents the data as entered.
Input Field
|
Entered
|
SERIAL NUMBER |
77112231 |
LAW OFFICE ASSIGNED |
LAW OFFICE 101 |
MARK SECTION |
STANDARD CHARACTERS |
YES |
USPTO-GENERATED IMAGE |
YES |
LITERAL ELEMENT |
ARISTOPHANES |
OWNER SECTION (current) |
NAME |
Bristol-Myers Squibb Company |
STREET |
345 Park Avenue |
CITY |
New York |
STATE |
New York |
ZIP/POSTAL CODE |
10154 |
COUNTRY |
United States |
PHONE |
212 546-3661 |
FAX |
212 546-5664 |
OWNER SECTION (proposed) |
NAME |
Bristol-Myers Squibb Company |
INTERNAL ADDRESS |
Trademark Department |
STREET |
345 Park Avenue |
CITY |
New York |
STATE |
New York |
ZIP/POSTAL CODE |
10154 |
COUNTRY |
United States |
PHONE |
212 546-3661 |
FAX |
212 546-5664 |
GOODS AND/OR SERVICES SECTION |
INTERNATIONAL CLASS |
042 |
CURRENT IDENTIFICATION |
clinical trials for pharmaceutical preparations for human use |
GOODS OR SERVICES |
KEEP ALL LISTED |
EXTENSION SECTION |
EXTENSION NUMBER |
3 |
ONGOING EFFORT |
product or service research development |
ALLOWANCE MAIL DATE |
10/30/2007 |
STATEMENT OF USE |
NO |
PAYMENT SECTION |
NUMBER OF CLASSES |
1 |
SUBTOTAL AMOUNT |
150 |
TOTAL AMOUNT |
150 |
SIGNATURE SECTION |
SIGNATURE |
/Nadine Flynn/ |
SIGNATORY'S NAME |
Nadine P. Flynn |
SIGNATORY'S POSITION |
Assistant Secretary |
DATE SIGNED |
03/19/2009 |
FILING INFORMATION |
SUBMIT DATE |
Thu Mar 19 10:36:43 EDT 2009 |
TEAS STAMP |
USPTO/ESU-XXX.XX.XX.XX-20
090319103643889972-771122
31-440fe2392f2d4addf21b15
57d674240e5-DA-7628-20090
319103426386156 |
PTO Form 1581 (Rev 9/2005) |
OMB No. 0651-0054 (Exp. 09/30/2011) |
SOU Extension Request
(15 U.S.C. Section 1051(d))
To the Commissioner for Trademarks:
MARK: ARISTOPHANES
SERIAL NUMBER: 77112231
The applicant, Bristol-Myers Squibb Company, having an address of
Trademark Department
345 Park Avenue
New York, New York 10154
United States
requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application. The Notice of Allowance mailing date was 10/30/2007.
For International Class 042:
Current identification: clinical trials for pharmaceutical preparations for human use
The applicant has a continued bona fide intention to use or use through the applicant's related company or licensee the mark in commerce on or in connection with all of the goods and/or services
listed in the Notice of Allowance or as subsequently modified for this specific class.
This is the third extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods and/or services covered by
the extension request: product or service research development
A fee payment in the amount of $150 will be submitted with the form, representing payment for 1 class.
Declaration
The undersigned being hereby warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. Section 1001, and that such willful false statements
and the like may jeopardize the validity of this document, declares that he/she is properly authorized to execute this document on behalf of the Owner; and all statements made of his/her own
knowledge are true and that all statements made on information and belief are believed to be true.
Signature: /Nadine Flynn/ Date Signed: 03/19/2009
Signatory's Name: Nadine P. Flynn
Signatory's Position: Assistant Secretary
RAM Sale Number: 7628
RAM Accounting Date: 03/19/2009
Serial Number: 77112231
Internet Transmission Date: Thu Mar 19 10:36:43 EDT 2009
TEAS Stamp: USPTO/ESU-XXX.XX.XX.XX-20090319103643889
972-77112231-440fe2392f2d4addf21b1557d67
4240e5-DA-7628-20090319103426386156